Tapping Compliance Data to Drive Success

How pharma leaders can convert data collected for compliance purposes from a cost center into a critical success factor In the pharmaceutical sector, manufacturers have become accustomed to the significant and increasing "burden" of regulatory compliance demanding that they update their processes, systems, and skills to accommodate the latest reporting requirements. Basing compliance activity on structured, ready-to-go data, in a consistent format, means the latest, correct information can be called up and prepared at speed using the latest digital tools to ensure efficient data exchanges with authorities, with full details and a clear line of sight across every product's lifecycle for reliability, traceability, and protected data access. Here, risk management plans involve anticipating and paying close attention to an initial holistic review of all aspects (both positive and negative) of a product from its earliest development stages, allowing companies to anticipate and mitigate the safety profile of each drug.